Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample

Diabetologia(2021)10.1007/s00125-021-05523-2Source: DataRank Database

Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample is a research paper published in Diabetologia (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access33 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (53 grants)Impact (FWCI 2.41)OA: hybridTopics (74)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Connie S.N. Li Wai Suen ORCID,Michael J. Haller ORCID,Stephen E. Gitelman ORCID,Carmella Evans‐Molina ORCID,Peter A. Gottlieb ORCID

Live enrichment

PubMed:34338806 PMC:PMC8494707 OpenAlex:https://openalex.org/W3188141723

National Health and Medical Research Council

Grant: 1150425, 1173945

Juvenile Diabetes Research Foundation International

Grant: 1-SRA-2020-900, 1-SRA-2014-310-M-R, 3-SRA-2015-72-

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK061010, U01 DK061034, U01 DK061042, U01 DK06

Leona M. and Harry B. Helmsley Charitable Trust

Grant: G-1911-03274

LifeScience-Stiftung

Grant: HMGU 2014.01, HMGU 2016.01

NIDDK NIH HHS

Grant: U01 DK085461

NIDDK NIH HHS

Grant: U01 DK106993

NIDDK NIH HHS

Grant: U01 DK061010

NIDDK NIH HHS

Grant: U01 DK107013

NIDDK NIH HHS

Grant: UC4 DK106993

NIDDK NIH HHS

Grant: U01 DK061034

NIDDK NIH HHS

Grant: U01 DK061042

NIDDK NIH HHS

Grant: U01 DK127786

NIDDK NIH HHS

Grant: P30 DK097512

NIDDK NIH HHS

Grant: U01 DK085476

NIDDK NIH HHS

Grant: U01 DK103153

NIDDK NIH HHS

Grant: U01 DK107014

NIDDK NIH HHS

Grant: UC4 DK117009

NIDDK NIH HHS

Grant: U01 DK061058

NIDDK NIH HHS

Grant: U01 DK085453

NIDDK NIH HHS

Grant: U01 DK085466

NIDDK NIH HHS

Grant: U01 DK085499

NIDDK NIH HHS

Grant: U01 DK085504

NIDDK NIH HHS

Grant: U01 DK085509

NIDDK NIH HHS

Grant: U01 DK103282

NIDDK NIH HHS

Grant: U01 DK106984

NIDDK NIH HHS

Grant: U01 DK106994

NIDDK NIH HHS

Grant: U01 DK103180

NIDDK NIH HHS

Grant: R01 DK127308

NIDDK NIH HHS

Grant: U01 DK085465

NIDDK NIH HHS

Grant: U01 DK103266

National Institutes of Health

Grant: 5U01DK085461-10

TrialNet: University of Florida Clinical Center and Network

National Institutes of Health

Grant: 1U01DK085453-01

Type 1 Diabetes TrialNet: Clinical Centers (U01)

National Institutes of Health

Grant: 5U01DK061058-15

Prediction and Prevention of Type 1 Diabetes (TrialNet)

National Institutes of Health

Grant: 5U01DK085465-03

Vanderbilt University: Clinical Center Application, Type 1 Diabetes TrialNet

National Institutes of Health

Grant: 5U01DK103282-04

Type 1 Diabetes TrialNet Clinical Network Hub

National Institutes of Health

Grant: 5U01DK061034-07

Northwest Clinical Center for Type 1 Diabetes - TrialNet

National Institutes of Health

Grant: 1U01DK061010-01

UCSF TrialNet: A Phase II Trial of hokT3gamma1 (Ala-Ala)

National Institutes of Health

Grant: 5U01DK085476-03

Type 1 Diabetes-A Proposal for Prevention & Intervention

National Institutes of Health

Grant: 5U01DK061042-16

TrialNet at Stanford University

National Institutes of Health

Grant: 5U01DK085499-03

Type 1 Diabetes TrialNet Clinical Center: Effects of Alefacept in New Onset T1D

National Institutes of Health

Grant: 5U01DK107013-04

Type 1 Diabetes TrialNet: Toronto Clinical Center

National Institutes of Health

Grant: 5U01DK085504-05

Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University

National Institutes of Health

Grant: 5U01DK106984-02

Type 1 Diabetes TrialNet Clinical Centers - Kansas City

National Institutes of Health

Grant: 5U01DK085466-02

Type 1 Diabetes TrialNet: Clinical Center at Yale University (U01)

National Institutes of Health

Grant: 5U01DK106994-02

An Atlanta TrialNet Center: Building a Pathway to 70 Clinical Trial Subjects per Year

National Institutes of Health

Grant: 1UC4DK106993-01

NIDDK Type 1 Diabetes TrialNet Data Coordinating Center

National Institutes of Health

Grant: 5U01DK103153-03

Chicagoland Diabetes TrialNet Clinical Center

National Institutes of Health

Grant: 1U01DK085509-01

Trainet: Diabetes Type 1 Prevention

National Institutes of Health

Grant: 5U01DK107014-04

Type 1 Diabetes TrialNet at Indiana University Clinical Center

National Institutes of Health

Grant: 5U01DK103266-02

USF TrialNet Clinical Center

National Health and Medical Research Council (NHMRC)

Grant: 1150425

Intervening in the natural history of type 1 diabetes: an integrated approach

National Institutes of Health

Grant: 5U01DK103180-03

Texas Children's Hospital and Baylor College of Medicine TrialNet Clinical Center

FWCI

2.41

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00125-021-05523-2.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00125-021-05523-2.pdf

publisherhttps://link.springer.com/article/10.1007/s00125-021-05523-2/fulltext.html

journalhttps://doi.org/10.1007/s00125-021-05523-2

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34338806

Fields of Study

Diabetes and associated disordersDiabetes Management and ResearchPancreatic function and diabetes0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

Zinc Transporter 8AdolescentAutoantibodiesBlood GlucoseC-PeptideChildChild, PreschoolDiabetes Mellitus, Type 1FemaleGlucose Tolerance TestGlycated HemoglobinHumansInsulin AntibodiesMaleROC CurveBody Mass IndexProportional Hazards ModelsDisease ProgressionArea Under CurveReceptor-Like Protein Tyrosine Phosphatases, Class 8Asymptomatic Diseases

Keywords

MedicineType 2 diabetesType 1 diabetesInternal medicineDiabetes mellitusPopulationBlood samplingReceiver operating characteristicDiseaseArea under the curveProportional hazards modelKetoacidosisOncologyEndocrinologyPredictionPreventionRisk stratificationDisease ProgressionOgttBlood GlucoseMaleGlycated Hemoglobin AAdolescentInsulin AntibodiesReceptor-Like Protein Tyrosine Phosphatases610Zinc Transporter 8ArticleBody Mass IndexHumansReceptor-Like Protein Tyrosine Phosphatases, Class 8PreschoolChildAutoantibodiesProportional Hazards ModelsGlycated HemoglobinC-PeptideDisease Progression ; Ogtt ; Prediction ; Prevention ; Risk Stratification ; Type 1 DiabetesGlucose Tolerance TestClass 8Diabetes Mellitus, Type 1ROC CurveArea Under CurveChild, PreschoolAsymptomatic DiseasesFemaleType 1

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being